Hazard of death among patients with B-ALL from phase 2 of TARGET according to USP9X expression
| Group . | HR . | 95% CI . | P value . |
|---|---|---|---|
| Intermediate quartile (USP9X expression) | 1.1 | 0.63-1.88 | .76 |
| Lower quartile (USP9X expression) | 2.0 | 1.09-3.71 | .02 |
| Sex (male) | 1.3 | 0.85-2.04 | .21 |
| Protocol (AALL0331) | 1.1 | 0.74-1.79 | .54 |
| Group . | HR . | 95% CI . | P value . |
|---|---|---|---|
| Intermediate quartile (USP9X expression) | 1.1 | 0.63-1.88 | .76 |
| Lower quartile (USP9X expression) | 2.0 | 1.09-3.71 | .02 |
| Sex (male) | 1.3 | 0.85-2.04 | .21 |
| Protocol (AALL0331) | 1.1 | 0.74-1.79 | .54 |